Launch compliant AI-native campaigns for pharma & life sciences
Location: United States
Total raised: $21M
Investors 2
| Date | Name | Website |
| 29.12.2024 | Virtue | virtuevc.c... |
| 01.07.2025 | Twelve Bel... | twelvebelo... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 28.05.2026 | Series A | $21M | Leerink Tr... |
Mentions in press and media 3
| Date | Title | Description |
| 28.05.2026 | Solstice Secures $21M for AI-Native Pharmaceutical Marketing Platform From 3 Months to 10 Days: Why Solstice Raised $21M to Automate Pharma MLR Workflows | What You Should Know AI-native pharmaceutical marketing platform Solstice has announced a $21M Series A funding round led by Transformation Capital, bringing its total funding footprint to approximately $25M. The financing, featuring partic... |
| 28.05.2026 | Solstice Raises $21M in Series A Funding | Solstice, a NYC-based AI-native marketing agency accelerating pharma commercialization, raised $21M in Series A funding. The round was led by Transformation Capital with participation from Twelve Below, Virtue Ventures and others. The raise... |
| - | Solstice Health | “AI Engine for Life Sciences Marketing” |